Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

JANX

Janux Therapeutics, Inc.

CIK 0001817713 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$16.75
↑ 0.09 (0.54%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 4/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership, Options; Risks: Fundamentals

Key stats

Market Cap
$1.02B
P/E Ratio
-8.92
EPS
-1.83
Dividend Yield
Not covered
52W Position
20%
Beta
1.25

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
1.08
P/S
74.38
EV/Revenue
70.61
ROE
-12.2%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 20%
$12.12$35.34

Latest Financials

2025-12-31 FY
Revenue
$10.00M
Net Income
-$113.63M
Total Assets
$1.00B
Free Cash Flow
-$83.28M

Recent news